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Abstract
Smoking usually begins in adolescence, and early onset of smoking has been linked to increased risk of later life disease.
There is a need to better understand the biological impact of cigarette smoking behaviours in adolescence. DNA
methylation profiles related to smoking behaviours and cessation in adulthood have been previously identified, but
alterations arising from smoking initiation have not been thoroughly investigated. We aimed to investigate DNA
methylation in the Avon Longitudinal Study of Parents and Children in relation to (1) different smoking measures, (2) time
since smoking initiation and frequency of smoke exposure and (3) latent classes of smoking behaviour. Using 2620 CpG sites
previously associated with cigarette smoking, we investigated DNA methylation change in relation to own smoking
measures, smoke exposure duration and frequency, and using longitudinal latent class analysis of different smoking
behaviour patterns in 968 adolescents. Eleven CpG sites located in seven gene regions were differentially methylated in
relation to smoking in adolescence. While only AHRR (cg05575921) showed a robust pattern of methylation in relation to
weekly smoking, several CpGs showed differences in methylation among individuals who had tried smoking compared with
non-smokers. In relation to smoke exposure duration and frequency, cg05575921 showed a strong dose–response
relationship, while there was evidence for more immediate methylation change at other sites. Our findings illustrate the
impact of cigarette smoking behaviours on DNA methylation at some smoking-responsive CpG sites, even among
individuals with a short smoking history.
Introduction
Smoking commonly begins in adolescence (1), with 19% of ado-
lescents (11- to 15-year-olds) in the UK having ever smoked
in 2016 (2). While this percentage has been decreasing, from
49% in 1996 (3), early onset of smoking has been linked to an
increased risk of cancer (4,5) and other diseases (6,7) in later life.
Although the harms increase with increased smoking intensity
and duration, even light smokers are at increased risk com-
pared with people who don’t smoke (8). Consequently, there is
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a need to understand the biological impact of cigarette smoking
behaviours in adolescence. Findings may also allow a more
informed education to be given to adolescence concerning the
harms of any amount of smoking.
Cigarette smoking has been associated with DNA methy-
lation in several recent epigenome-wide association studies
(EWAS) (9–16). This differential methylation in relation to
smoke exposure has also been linked to disease, including a
number of epithelial cancers (17,18), and therefore could be
used as a potential biomarker of both smoking status, length
of smoking history and in turn as a predictor of disease risk
(9,17). However, site-specific DNA methylation in response to
smoking is dynamic and can change over time. Although several
studies have investigated the extent to which changes in DNA
methylation that are associated with smoking persist after
smoking cessation (10,19,20), the length of time required for
smoking to impact on DNA methylation has not been fully
evaluated.
Several studies have shown that smoking is associated with
site-specific DNA methylation among young people and adoles-
cents (12,21,22), suggesting that methylation changes may be
induced after a relatively short smoking history. However, these
studies have typically evaluated methylation at only a few CpG
sites and have not modelled methylation changes with time
since smoking initiation or considered the impact of light or
occasional smoking on DNA methylation.
Furthermore, previous studies have not thoroughly consid-
ered the potential confounding effect of maternal smoking in
pregnancy on associations between own smoking and DNA
methylation in adolescence, which is important given the
strong overlap in DNA methylation profiles among smokers and
those exposed to smoke in utero, and the persistent impact of
prenatal smoke exposure on DNA methylation at some CpG
sites across the lifecourse (23). In addition, it is of interest
to evaluate whether adolescents exposed to smoke in utero
are more susceptible to further change in DNA methylation
levels at candidate CpG sites when they initiate smoking
compared to those not exposed in utero. This work aimed
to investigate DNA methylation measured by the Illumina
Infinium® HumanMethylation450 (HM450) BeadChip in the
Avon Longitudinal Study of Parents and Children (ALSPAC)
adolescents (median age 17 years 7 months; hereafter referred
to as 17 years) in relation to (1) different smoking exposures
(ever smoking, current weekly smoking, ever weekly smoking
and blood cotinine levels), (2) time since smoking initiation
and frequency of smoke exposure and (3) several latent classes
of smoking behaviour (non-smoker, experimenters, late-onset
regular smokers and early-onset regular smokers) (24).
Results
Study sample
A total of 968 individuals in the Accessible Resource for Inte-
grated Epigenomics Studies (ARIES) subsample of ALSPAC had
DNA methylation derived from samples taken in adolescence
(mean age 17 years) (25). Information on ever smoking across all
three questionnaires (ages 14, 15 and 16) was available for 932
individuals (Fig. 1). Of the 834 individuals with information on
current weekly smoking, 73 were classified as weekly smokers
while 761 were classified as less than weekly smokers at age 16.
Individuals who were weekly smokers in ARIES were more likely
to be female, to be slightly younger, to regularly use cannabis,
to drink regularly and to have used substances than non-weekly
Figure 1. Participant flow diagram illustrating participants included in this
analysis.
smokers and were more likely to have been exposed to mater-
nal smoking during pregnancy (Table 1). Comparisons between
participants based on the other smoking definitions and latent
classes are shown in Table S1.
Multivariable linear regression with own smoking
behaviours
Using information on ever smoking and ever weekly smoking
derived from questionnaires obtained at ages 14–16, as well as
current weekly smoking and blood cotinine levels obtained at
age 16, multivariable linear regression was used to identify CpG
sites associated with smoke exposure in adolescence. Specifi-
cally, we investigated methylation β values for 2620 out of 2623
CpGs previously identified in a large-scale EWAS of smoking (10)
which were available in the normalized dataset for the ARIES
offspring in adolescence (mean age 17 years). CpG sites identified
in a basic multivariable linear regression model adjusted for
batch and cell count were investigated in additional regression
models with adjustment for potential confounders. Due tomiss-
ing covariate data, multiple imputation (MI) of covariates was
carried for the adjusted models (as outlined in Table S2).
Ever smoking. For ever smoking, four CpGs passed the
Bonferroni-corrected threshold in the basic model; cg19593285
(E2F1), cg02512902 (KSR1),cg03519879 (C14ORF43) and cg13951797
(TRAF7). For these sites, there was a reduction in methylation
in relation to ever smoking (ranging from 1.1 and 1.4% in the
Adjusted Model 1) which showed some degree of attenuation
with further covariate adjustment (ranging from 0.7 to 1.2% in
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Table 1. Baseline characteristics of ARIES subsample of adolescents from the ALSPAC by current weekly smoking status
Variable ARIES
(n = 968)
Current weekly
smokers (n = 73)
Nonweekly smokers
(n = 761)
P-value difference
Sex (% Male) (n) 48.2 (467) 21.9 (16) 48.8 (371) < 0.001
Passive smoke exposure (% yes) (n) 49.3 (477) 58.9 (43) 43.1 (328) 0.009
Age at DNA methylation collection [mean (SD)] (n = 968) (n = 71) (n = 737)
17.1 (1.1) 17.0 (1.2) 17.2(1.0) 0.111
Maternal smoking during pregnancy (% yes) (n) (n = 945) (n = 66) (n = 725)
10.3 (97) 22.7 (15) 8.1 (59) < 0.001
Manual occupationsa [% (n)] (n = 879) (n = 60) (n = 684)
14.2 (125) 21.7 (13) 13.0 (89) 0.062
Regular alcohol consumption (%yes) (n) (n = 964) (n = 73) (n = 752)
50.4 (486) 79.4 (58) 48.9 (368) < 0.001
Substance use (n = 968) (n = 73) (n = 761)
Regular cannabis use (%yes) (n) 5.2 (50) 27.4 (20) 1.2 (9) < 0.001
Any substance use (%yes) (n) 43.4 (420) 89.0 (65) 34.0 (259) < 0.001
Missing current weekly smoking data (n = 134).
aBased on the 1991 OPCS classification.
theAdjustedModel 3). Sites cg19593285 (E2F1), cg02512902 (KSR1)
and cg13951797 (TRAF7) showed large attenuation of effects in
the fully adjusted model and this variable showed the highest
degree of attenuation with covariate adjustment (Table 2).
Current weekly smoking. Cg05575921 (AHRR) was the only CpG
site to pass the Bonferroni-corrected threshold with current
weekly smoking in all regression models. Adjusted Model 1
showed a methylation change of −3.8% between current weekly
smokers and non-weekly smokers (β = −0.038 (95% CI −0.048,
−0.027; P = 5.17x10−13), which remained largely unchanged after
additional covariate adjustment (β = −0.033 (95% CI -0.046,
−0.024, P = 7.56x10−10) in the fully adjusted model (Adjusted
Model 3) (Table 2).
Ever weekly smoking. Cg05575921 (AHRR) and cg08331398
(PSMB8) passed the Bonferroni-corrected threshold in relation
to ever weekly smoking in all regression models. In Adjusted
Model 1, for the AHRR site there was a methylation change
of −3.2% between ever weekly smokers and never weekly
smokers (β = −0.032 (95% −0.040, −0.024; P = 8.88x10−15),
which remained largely unchanged after additional covariate
adjustment (β = −0.028 (95% CI −0.037,−0.019; P = 4.05x10−10) in
the fully adjusted model (Adjusted Model 3)). In Adjusted Model
1, for PSMB8 there was a methylation change of −1.9% between
everweekly smokers and neverweekly smokers (β = −0.019 (95%
CI −0.027, −0.010; P = 2.17x10−5), which also remained largely
unchanged after additional covariate adjustment (β = −0.021
(95% CI −0.031, −0.012; P = 1.25x10−5) in Adjusted Model 3
(Table 2).
Blood cotinine levels. Six sites passed the Bonferroni-corrected
threshold in the basicmodel in relation to continuous blood coti-
nine levels; cg05575921 (AHRR), cg06338710 (GFI1), cg09935388
(GFI1), cg12876356 (GFI1), cg18146737 (GFI1) and cg26703534
(AHRR). For all sites, there was a reduction in methylation
(between −0.007 and −0.003 per 10 ng/ml) in Adjusted Model 1,
which attenuated slightly in the fully adjusted model (Adjusted
Model 3) (between −0.004 and −0.002 per 10 ng/ml) (Table 2).
Complete case sensitivity analysis
For the own smoking analysis, multivariable linear regression
was also performed using the complete cases for each model.
The results of the complete case analysis are largely consistent
with respect to effect estimates although P-values were larger
for the adjusted models (largely due to smaller sample size)
(Table S3).
Time since initiation and frequency of smoke exposure
We next investigated the patterns of methylation change with
years since individuals first smoked, years since individuals
started weekly smoking and intensity of smoke exposure. CpG
sites which passed the Bonferroni threshold in the basic model
of the multivariable linear regression analysis (Table 2) were
taken forward for this analysis. Figures 2A–2D shows the β dif-
ferences in methylation of the 11 CpG sites identified in the
own smoking linear regression compared with methylation in
the relevant non-smoking category for each variable, adjusted
for batch effect, cell count, age, sex, social class and maternal
smoking during pregnancy.
Several of the CpGs showed strong differences inmethylation
in relation to the time since the individual first ever smoked
(Fig. 2A), with evidence of a dose–response for some sites
[cg05575921 (AHRR) and cg02512902 (KSR1)] and a more imme-
diate impact of smoking on others [cg13951797 (TRAF7) and
cg19593285 (E2F1)]. Cg05575921 (AHRR) showed a similar dose–
response pattern in relation to time since starting weekly smok-
ing, while sites in GFI1 (cg09935388, cg12876356, cg06338710
and cg18146737) showed a more immediate impact of weekly
smoking (Fig. 2B). In relation to intensity of smoke exposure,
cg05575921 (AHRR) again showed a strong dose–response,
with decreasing levels of methylation in relation to intensity
of smoking behaviours and number of cigarettes smoked
(Fig. 2C and 2D). On the other hand, there was a more imme-
diate methylation change at cg13951797 (TRAF4), cg02512902
(KSR1) and cg19593285 (E2F1), which was largely maintained as
the number of cigarettes smoked increased (Fig. 2D).
Longitudinal latent class analysis
Using repeated measures of smoking frequency obtained from
questionnaire data at 14, 15 and 16 years, longitudinal latent
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/advance-article-abstract/doi/10.1093/hm
g/ddy316/5095321 by U
niversity of Bristol Library user on 14 N
ovem
ber 2018
4 Human Molecular Genetics, 2018, Vol. 00, No. 00
Ta
b
le
2.
M
u
lt
iv
ar
ia
bl
e
li
n
ea
r
re
gr
es
si
on
of
sm
ok
in
g
be
h
av
io
u
rs
an
d
D
N
A
m
et
h
yl
at
io
n
w
it
h
to
p
si
te
s
fr
om
ba
si
c
m
od
el
ta
ke
n
fo
rw
ar
d
to
m
od
el
s
1–
3
af
te
r
im
p
u
ta
ti
on
B
as
ic
m
od
el
A
d
ju
st
ed
m
od
el
1
A
d
ju
st
ed
m
od
el
2
A
d
ju
st
ed
m
od
el
3
A
d
ju
st
ed
m
od
el
4
Ev
er
sm
ok
ed
a
ci
ga
re
tt
e
re
li
ab
le
(n
=
50
4
ev
er
;n
=
43
5
n
ev
er
)
To
ta
ls
am
p
le
si
ze
91
0
cg
02
51
29
02
(K
SR
1)
−0
.0
16
−0
.0
23
,
−0
.0
09
3.
64
e-
06
−0
.0
14
−0
.0
21
,
−0
.0
07
6.
36
e-
05
−0
.0
12
−0
.0
19
,
−0
.0
04
0.
00
2
−0
.0
11
−0
.0
18
,
−0
.0
04
0.
00
3
−0
.0
11
−0
.0
19
,
−0
.0
04
0.
00
2
cg
19
59
32
85
(E
2F
1)
−0
.0
15
−0
.0
21
,
−0
.0
08
1.
83
e-
05
−0
.0
12
−0
.0
18
,
−0
.0
06
1.
13
e-
04
−0
.0
12
−0
.0
18
,
−0
.0
05
3.
30
e-
04
−0
.0
12
−0
.0
16
,
−0
.0
06
2.
44
e-
04
−0
.0
08
−0
.0
15
,
−0
.0
01
0.
02
9
cg
13
95
17
97
(T
R
A
F7
)
−0
.0
16
−0
.0
24
,
−0
.0
09
1.
34
e-
05
−0
.0
11
−0
.0
18
,
−0
.0
04
0.
00
3
−0
.0
08
−0
.0
16
,
−0
.0
01
0.
03
3
−0
.0
07
−0
.0
15
,
4.
46
e-
04
0.
06
5
−0
.0
09
−0
.0
16
,
−0
.0
01
0.
02
5
cg
03
51
98
79
(C
14
or
f4
3)
−0
.0
13
−0
.0
19
,
−0
.0
07
1.
80
e-
05
−0
.0
14
−0
.0
21
,
−0
.0
07
6.
36
e-
05
−0
.0
12
−0
.0
19
,
−0
.0
04
0.
00
2
−0
.0
11
−0
.0
18
,
−0
.0
04
0.
00
3
−0
.0
12
−0
.0
18
,-
0.
00
5
3.
93
e-
04
C
u
rr
en
t
w
ee
kl
y
sm
ok
in
g
(n
=
71
ye
s;
n
=
76
2
n
o)
To
ta
ls
am
p
le
si
ze
80
8
cg
05
57
59
21
(A
H
R
R
)
−0
.0
40
−0
.0
51
,
−0
.0
30
3.
10
e-
14
−0
.0
38
−0
.0
48
,
−0
.0
27
5.
17
e-
13
−0
.0
36
−0
.0
47
,
−0
.0
24
9.
39
e-
10
−0
.0
35
−0
.0
46
,
−0
.0
24
7.
56
e-
10
−0
.0
33
−0
.0
46
,
−0
.0
22
7.
35
e-
09
Ev
er
sm
ok
ed
w
ee
kl
y
(n
=
13
2
ev
er
;n
=
84
8
n
ev
er
)
To
ta
ls
am
p
le
si
ze
94
9
C
g0
55
75
92
1
(A
H
R
R
)
−0
.0
35
−0
.0
43
,
−0
.0
27
5.
90
e-
17
−0
.0
32
−0
.0
24
,
−0
.0
40
8.
88
e-
15
−0
.0
28
−0
.0
37
,
−0
.0
19
1.
38
e-
09
−0
.0
28
−0
.0
37
,
−0
.0
19
4.
05
e-
10
−0
.0
28
−0
.0
37
,
−0
.0
19
4.
85
e-
10
C
G
08
33
13
98
(P
SM
B
8)
−0
.0
20
−0
.0
28
,
−0
.0
11
4.
88
e-
06
−0
.0
19
−0
.0
10
,
−0
.0
27
2.
17
e-
05
−0
.0
22
−0
.0
31
,
−0
.0
12
1.
36
e-
05
−0
.0
21
−0
.0
31
,
−0
.0
12
1.
25
e-
05
−0
.0
20
−0
.0
30
,
−0
.0
11
3.
84
e-
05
C
ot
in
in
e
in
th
e
bl
oo
d
10
n
g/
m
l
To
ta
ls
am
p
le
si
ze
77
0
C
G
05
57
59
21
(A
H
R
R
)
−0
.0
04
−0
.0
05
,
−0
.0
03
4.
19
e-
16
−0
.0
04
−0
.0
05
,
−0
.0
03
3.
24
e-
13
−0
.0
03
−0
.0
04
,
−0
.0
02
6.
01
e-
10
−0
.0
03
−0
.0
04
,
−0
.0
02
2.
79
e-
10
−0
.0
03
−0
.0
04
,
−0
.0
02
1.
41
e-
10
C
G
06
33
87
10
(G
FI
1)
−0
.0
06
−0
.0
08
.,
−0
.0
03
1.
73
e-
06
−0
.0
06
−0
.0
08
,
−0
.0
03
2.
12
e-
06
−0
.0
06
−0
.0
08
,
−0
.0
03
2.
91
e-
05
−0
.0
04
−0
.0
07
−0
.0
02
3.
67
e-
04
−0
.0
04
−0
.0
06
,
−0
.0
01
7.
30
e-
04
C
G
09
93
53
88
(G
FI
1)
−0
.0
07
−0
.0
09
,
−0
.0
04
2.
98
e-
08
−0
.0
06
−0
.0
09
,
−0
.0
04
2.
35
e-
07
−0
.0
06
−0
.0
09
,
−0
.0
04
1.
15
e-
06
−0
.0
04
−0
.0
05
,
−0
.0
02
5.
67
e-
05
−0
.0
05
−0
.0
07
,
−0
.0
03
4.
86
e-
07
C
G
12
87
63
56
(G
FI
1)
−0
.0
07
−0
.0
10
,
−0
.0
04
1.
74
e-
06
−0
.0
07
−0
.0
10
,
−0
.0
04
4.
09
e-
06
−0
.0
07
−0
.0
10
,
−0
.0
04
2.
01
e-
05
−0
.0
04
−0
.0
06
,
−0
.0
02
4.
29
e-
04
−0
.0
05
−0
.0
07
,
−0
.0
02
2.
81
e-
04
C
G
18
14
67
37
(G
FI
1)
−0
.0
06
−0
.0
08
,
−0
.0
03
1.
29
e-
05
−0
.0
06
−0
.0
09
,
−0
.0
03
2.
21
e-
05
−0
.0
06
−0
.0
09
,
−0
.0
03
4.
19
e-
05
−0
.0
02
−0
.0
03
,
−7
.4
7e
-0
4
0.
00
2
−0
.0
04
−0
.0
06
,
−0
.0
01
9.
54
e-
04
C
G
26
70
35
34
(A
H
R
R
)
−0
.0
03
−0
.0
04
,
−0
.0
02
3.
11
e-
07
−0
.0
03
−0
.0
04
,
−0
.0
01
2.
04
e-
06
−0
.0
02
−0
.0
04
,
−0
.0
01
1.
17
e-
05
−0
.0
02
−0
.0
03
,
−7
.4
7e
-0
4
1.
19
e-
05
−0
.0
02
−0
.0
04
,
−0
.0
01
1.
26
e-
05
B
as
ic
m
od
el
:A
d
ju
st
ed
m
od
el
fo
r
ba
tc
h
an
d
ce
ll
co
u
n
t.
A
d
ju
st
ed
m
od
el
1:
A
d
ju
st
ed
m
od
el
fo
r
ba
tc
h
,c
el
lc
ou
n
t,
ag
e,
se
x,
so
ci
al
cl
as
s
an
d
m
at
er
n
al
sm
ok
in
g
d
u
ri
n
g
p
re
gn
an
cy
.
A
d
ju
st
ed
m
od
el
2:
A
d
ju
st
ed
m
od
el
fo
r
ba
tc
h
,c
el
lc
ou
n
t,
ag
e,
se
x,
so
ci
al
cl
as
s,
re
gu
la
r
ca
n
n
ab
is
u
se
,r
eg
u
la
r
al
co
h
ol
u
se
,p
as
si
ve
sm
ok
e
an
d
m
at
er
n
al
sm
ok
in
g
d
u
ri
n
g
p
re
gn
an
cy
.
A
d
ju
st
ed
m
od
el
3:
A
d
ju
st
ed
m
od
el
fo
r
ba
tc
h
,c
el
lc
ou
n
t,
ag
e,
se
x,
so
ci
al
cl
as
s,
re
gu
la
r
ca
n
n
ab
is
u
se
,r
eg
u
la
r
al
co
h
ol
u
se
,p
as
si
ve
sm
ok
e,
m
at
er
n
al
sm
ok
in
g
d
u
ri
n
g
p
re
gn
an
cy
an
d
m
et
h
yl
at
io
n
at
ag
e
7.
A
d
ju
st
ed
m
od
el
4:
A
d
ju
st
ed
m
od
el
fo
r
ba
tc
h
,c
el
lc
ou
n
t,
ag
e,
se
x,
so
ci
al
cl
as
s,
re
gu
la
r
ca
n
n
ab
is
u
se
,r
eg
u
la
r
al
co
h
ol
u
se
,p
as
si
ve
sm
ok
e,
m
at
er
n
al
sm
ok
in
g
d
u
ri
n
g
p
re
gn
an
cy
an
d
co
rd
bl
oo
d
m
et
h
yl
at
io
n
.
B
on
fe
rr
on
it
h
re
sh
ol
d
=
1.
91
e-
05
.
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/advance-article-abstract/doi/10.1093/hm
g/ddy316/5095321 by U
niversity of Bristol Library user on 14 N
ovem
ber 2018
Human Molecular Genetics, 2018, Vol. 00, No. 00 5
A B
C D
Figure 2. (A) Difference in methylation between time since individuals first ever smoked and never smokers. Adjusted for batch effect, cell count, age, sex, social class
and maternal smoking during pregnancy. (B) Difference in methylation between time since individuals started weekly smoking and never smokers. Adjusted for batch
effect, cell count, age, sex, social class and maternal smoking during pregnancy. (C) Difference in methylation between smoking intensity and never smokers. Adjusted
for batch effect, cell count, age, sex, social class and maternal smoking during pregnancy. (D) Difference in methylation between number of cigarettes ever smoked and
never smokers. Adjusted for batch effect, cell count, age, sex, social class and maternal smoking during pregnancy.
class analysis (LLCA) was performed using Mplus v8 (26), as has
been described previously (24). A 4-class model was selected for
the repeated measures of smoking frequency (see Table S4 for
model fit statistics). This 4-class solution comprised smoking
behaviour patterns that we refer to as never-smokers (86%),
experimenters (5%), late onset regular smokers (9%) and early
onset regular smokers (1%). These classes are consistent with
those derived previously by Heron and colleagues (24), where
non-smokers reported very little or no smoking, experimenters
smoked infrequently (monthly), late-onset regular smokerswere
individuals who began smoking by age 14 and were mostly
daily smokers by age 16 and early-onset regular smokers were
mostly daily smokers by age 14. Figure S1 shows the within-class
probabilities for the repeated measures of smoking frequency.
Given the very high entropy of the 4-class model (0.94), individ-
uals were assigned to the class for which they had the highest
probability of class membership (modal class assignment) and
the latent classes were used as an observed categorical exposure
in further analyses.
CpG sites that passed the Bonferroni-corrected threshold in
the basic model of the linear regression analysis were taken
forward for the LLCA. Three of the 11 identified CpG sites from
the linear regression analyses passed the Bonferroni-corrected
threshold in the association with the latent classes [p = 0.0045
(0.05/11)]: cg05575921 (AHRR), identified in relation to total
number of cigarettes smoked and current smoking, cg08331398
(PSMB8), which was identified in relation to individuals who
had ever smoked weekly and cg26703534 (AHRR), identified
in the continuous blood cotinine levels analysis. Cg05575921
(AHRR) was found to be differentially methylated across the
latent classes (P = 5.3 × 10−10) in a dose–response manner,
whereby early onset regular smokers had a 5.4% (95% CI
−2.8, −8.1) reduction in methylation compared with never
smokers, late onset smokers had a 2.5% (−1.7,−3.4) reduction in
methylation and experimenters have a 0.1% (−1.3, 1.1) reduction
in methylation. Methylation at PSMB8 (P = 0.0026) was most
strongly associated with late onset (versus never) smoking,
where late onset smokers had a 1.7% reduction in methylation
compared with never smokers (95% CI 0.8, 2.6). Cg26703534
(AHRR) was also found to be differentially methylated across
the latent classes (P = 7.0 × 10−4) in a dose–response manner,
whereby early onset regular smokers had a 5.2% (95% CI −7.9,
−2.4) reduction in methylation compared with never smokers,
late onset smokers had a 0.9% (−1.8, −4.6x10−5) reduction in
methylation and experimenters have a 0.6% (−1.8, 0.6) reduction
in methylation (Table 3).
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Table 3. Latent class analysis for the 11 CpGs identified in linear regression analysis
Overall
(n = 931)
Early onset (n = 8) versus
never (n = 800)
Late onset (n = 80) versus
never (n = 800)
Experimenter (n = 43)
versus never (n = 800)
CpG site P-value of f-test
for model fit
β 95% CI β 95%CI β 95% CI
cg05575921 (AHRR) 5.32E-10 −0.054 −0.081, −0.028 −0.025 −0.034, −0.017 −0.001 −0.013, 0.011
cg26703534 (AHRR) 6.98E-04 −0.052 −0.079, −0.024 −0.009 −0.018, −4.57E-05 −0.006 −0.018, 0.006
cg08331398 (PSMB8) 2.65E-03 0.012 −0.016, 0.040 −0.017 −0.026, −0.008 −0.007 −0.020, 0.005
cg09935388 (GFI1) 0.019 −0.039 −0.100, 0.023 −0.030 −0.050, −0.010 0.004 −0.023, 0.031
cg02512902 (KSR1) 0.021 −0.004 −0.035, 0.028 −0.012 −0.023, −0.002 −0.016 −0.030, −0.002
cg03519879 (C14orf43) 0.023 0.011 −0.018, 0.040 −0.013 −0.022, −0.003 −0.010 −0.023, 0.002
cg06338710 (GFI1) 0.042 −0.043 −0.107, 0.021 −0.028 −0.049, −0.049 −0.007 −0.035, 0.021
cg12876356 (GFI1) 0.045 −0.028 −0.095, 0.039 −0.031 −0.053, −0.009 0.002 −0.028, 0.031
cg18146737 (GFI1) 0.069 −0.001 −0.080, 0.077 −0.034 −0.060, −0.008 0.010 −0.024, 0.045
cg13951797 (TRAF7) 0.248 −0.028 −0.063, 0.007 −0.005 −0.017, 0.006 −0.009 −0.024, 0.007
cg19593285 (E2F1) 0.954 0.007 −0.025, 0.039 −0.001 −0.012, 0.009 −0.002 −0.016, 0.012
Models adjusted for batch, cell count, age, sex, social class and maternal smoking in pregnancy. Bonferroni threshold: 0.0045.
Interaction analysis
The interaction between the four own smoking measures: ever
tried a cigarette, current weekly smoker, ever smoked on a
weekly basis and blood cotinine levels and maternal smoking
during pregnancywas tested on 119 CpG sites found to be associ-
atedwith both own (10) andmaternal smoking during pregnancy
(27) in two large EWAS. One CpG site passed the Bonferroni-
corrected threshold for interaction with cotinine: cg06338710
(GFI1) (P = 3.86 × 10−4) (full results in Table S5), where there was
evidence for a greater reduction in DNAmethylation in response
to cotinine among adolescents exposed to maternal smoking in
pregnancy than those who weren’t (Fig. S2).
Cell counts
To investigate the potential role of cell sub-composition inmedi-
ating the impact of smoke exposure on DNA methylation, we
investigated associations between the smoking behaviours and
cell-type fraction estimated using the methylation data (28,29).
Ever smoking and current weekly smoking in adolescence were
not strongly associated with cell-type fractions, with the excep-
tion of CD4 T cell count which was higher among currently
weekly smokers compared with non-smokers at age 17 (differ-
ence in proportion= 0.018 (95%CI 0.006, 0.031; p= 0.005 inmodel
adjusted for age 7 cell counts), which is consistent with previ-
ous findings (30) (Table S6). However, all analyses investigated
adjustment for derived cell count proportions, which were not
generally shown to attenuate results.
Discussion
We investigated methylation at 2620 CpG sites previously asso-
ciated with smoking in a large-scale EWAS (10) in relation to
smoking behaviours of a cohort of adolescents. Eleven CpG sites
showed robust associations with various smoking behaviours:
ever smoking, currentweekly smoking, everweekly smoking and
blood cotinine levels. Furthermore, the associations we observed
were largely supported by analysis of methylation in relation to
duration and frequency of smoke exposure, and in LLCA which
was used to group adolescents based on their smoking habits.
Cg05575921 (AHRR) showed the strongest degree of differen-
tial methylation with current smoking but did not appear in
ever smoking analysis, suggesting that a longer and sustained
smoking history is required for this site to become differentially
methylated. This is supported by the finding of a dose–response
in methylation at this site in relation to both duration and
intensity of smoke exposure. Furthermore, both cg05575921 and
cg26703534, also annotated to AHRR, were found to be strongly
associated with blood cotinine levels and in the relation to early
onset regular smoking in the latent class analysis.
While other studies have suggested that only a short smoking
history is required for cg05575921 (AHRR) to become differen-
tially methylated (15,31), these studies have not outlined the
exact time frame required for this to become established. Results
of our study suggest that hypomethylation at this site becomes
apparent with ≥4 years smoke exposure, and with smoking at
least once a week. This is consistent with the finding by Philibert
et al. (12), where associations were observed with less than one-
half pack year of smoke exposure. Cg05575921 and cg26703534
are situated in intron 3 of the aryl hydrocarbon receptor repres-
sor (AHRR) gene on chromosome 5. Cg05575921 has been previ-
ously identified in relation to smoke exposure in several EWAS
and is frequently found to be the CpG site most strongly asso-
ciated with exposure (10,15,21,31,32). Cg05575921 (AHRR) methy-
lation has also been identified as a potential biomarker for lung
cancer (33) and subclinical atherosclerosis in smokers (32).
Cg02512902 (KSR1) and cg03519879 (C14ORF43) were consis-
tently associated with ever smoking and showed evidence for
differential methylation with a small degree of smoke exposure,
whichwas thenmaintainedwith increased duration of smoking.
There was also evidence for an association between KSR1 and
C14ORF43 methylation and the latent classes, with the largest
degree of differential methylation among the late onset smokers
and experimenters compared with non-smokers. Cg08331398
(PSMB8) was strongly associated with ever weekly smoking in all
linear regressionmodels and also with late onset smoking in the
latent class analysis.
Cg02512902 maps to the Kinase Suppressor of Ras 1 (KSR1)
gene which transcribes proteins that positively regulate the Ras
signalling pathway (34). It has been associated with cancer and
identified as a potential therapeutic target (35). Cg03519879maps
to the C14ORF43 gene, synonymous with ELMSAN1, which has
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not been researched considerably but is thought to play a role
in chromatin binding. Cg08331398 maps to the PSMB8 gene and
has been associated with several types of cancer (36–39) and
hepatitis B (40,41).
Sites in GFI1 (cg09935388, cg12876356, cg06338710 and
cg18146737) were identified in the analysis of blood cotinine
levels and there was evidence for a more immediate impact of
weekly smoking on these sites. The growth factor independent 1
transcriptional repressor gene (GFI1) is most highly expressed in
the bone marrow and has been associated with immune system
disruption, and conditions such as haematopoiesis,neutropenia,
leukaemia and prostate cancer among others (42–46). At GFI1
(cg06338710) there was also some evidence for an interaction
between own smoking and maternal smoking in adolescence.
A key strength of this study is the longitudinal cohort design,
which enabled an evaluation of DNA methylation in relation to
smoking behaviour reported at multiple time points in adoles-
cence.The quantity of smoking data obtained from the question-
naires,which captured different elements of smoking behaviour,
enabled an evaluation of different types of smoking behaviour.
Use of multiple time points allowed us to derive a more reliable
measure of ever smoking, to explore the dynamics of methy-
lation in relation to time since smoking initiation (first trying
and first regularly smoking) and smoking intensity and per-
mitted the LLCA. Furthermore, as DNA methylation data at
birth and age 7 were available, adjustment for baseline levels of
methylation in latermodels ameliorated risk of reverse causality
(i.e. where methylation influenced smoking behaviour rather
than vice versa). The wealth of phenotypic data in ALSPAC has
aided a thorough assessment of potential confounding factors,
and MI was used to account for missing data in order to fully
evaluate this.
The first limitation of the analysis is that the ARIES cohort
represents a highly selected sample of participants who are not
representative of thewider ALSPAC cohort (25). This is illustrated
with the small number of smokers in this adolescent cohort,
with only 73 people (10%) identified as at least weekly smokers
at age 16, compared with an estimated 15% among individuals
who provided partial smoking information in the wider ALSPAC
cohort (24).While we attempted tomaximize power in this study
by only focusing on those CpGs which have been previously
identified as being responsive to tobacco smoke (10), potential
selection bias in this setting remains an issue (47). The second
limitation is that some individuals inconsistently reported their
smoking behaviour across the three-time points, which reduced
the reliability of the smoking data. Although we derived a vari-
able for ever smoking to account for this inconsistency, across
all the own smoking variables there may have been more unre-
liable responses that could have affected the results. Thirdly,
differential measurement error of mothers’ reporting of her own
smoking behaviour during pregnancy could also have biased
associations. Fourthly, this analysiswas limited to blood samples
with mixed cell composition. While models were adjusted for
derived cell counts and the analysis was based on CpG sites
with robust associations with smoke exposure, which were not
driven by cellular heterogeneity, the limitation of tissue speci-
ficity as well as the lack of expression data currently available on
these samples limits the assessment of functional consequences
of these methylation changes. However, functional annotation
of the differentially methylated CpG sites suggests they are
involved in important pathways.
The results of this study illustrate the impact of cigarette
smoking on DNA methylation at some smoking-responsive
CpG sites even with a relatively limited smoking history.
This study supports previous evidence that methylation at
cg05575921 (AHRR) could serve as an important biomarker for
smoke exposure among adolescents (21), especially among
those with a longer smoking history and increases in a dose–
response manner in relation to both time since initiation
and frequency of smoke exposure. This study also implicates
other CpG sites that could serve as biomarkers of even shorter
smoking history, being evident among both late onset smokers
and experimenters. Although these findings were supported
in multiple models, replication of associations at these CpG
sites in an independent cohort is required. Further research is
also required to investigate the recovery of DNA methylation
at sites responsive to smoking within adolescence, especially if
these individuals do not go on to smoke regularly in adulthood.
Four of the 11 CpG sites identified here were identified in
a study investigating DNA methylation change in response
to smoking cessation (20): cg19593285 (E2F1), cg03519879
(C14ORF43), cg05575921 (AHRR) and cg26703534 (AHRR). Of
these four, DNA methylation changes were found to persist
for between 11 and 47 years after smoking cessation. However,
as this study investigated smoking cessation among a cohort
of adults who had likely had a much longer history of smoke
exposure, we cannot reliably infer a link between smoking
habits in adolescence and persistence in DNA methylation.
Therefore, future research is needed to investigate long-term
patterns of DNA methylation in individuals who smoked during
adolescence but not into adulthood. Finally, we advocate the
need for further downstream analyses to investigate potential
causal mechanisms by which DNA methylation may mediate
the impact of early life smoke exposure on later life disease risk.
Materials and Methods
Study participants
The ALSPAC is a large, prospective cohort study based in the
South West of England (48,49). A total of 14 541 pregnant
women resident in Avon, UK, with expected dates of delivery
April 1, 1991 to December 31, 1992 were recruited and detailed
information has been collected on these women and their
offspring at regular intervals. The study website contains details
of all the data that are available through a fully searchable
data dictionary (http://www.bris.ac.uk/alspac/researchers/data-
access/data-dictionary/). Written informed consent has been
obtained for all ALSPAC participants. Ethics approval for the
study was obtained from the ALSPAC Ethics and Law Committee
and the Local Research Ethics Committees. For this study, we
used data from the ARIES (25), a subsample of ALSPAC on
whom genome-wide DNA methylation data has been collected
at multiple time points.
Smoking variables
Information on smoking behaviour for the ARIES cohort came
from questionnaires completed at the median ages 14 years
2 months, 15 years 5 months and 16 years 7 months (hereafter
referred to as 14 years, 15 years and 16 years).
Ever smoking. A question on ever smoking was asked in all
three questionnaires up to and including age 16 years and used
to derive variable for ‘ever smoking’ (‘yes’ or ‘no’). From this
variable, we derived a more reliable variable for ‘ever smoking’
by removing those individuals who inconsistently reported their
smoking behaviour in the three questionnaires. For example, if
an individual reported ever smoking at the first-time point but
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not at the second or third, they were reported as missing. We
used this variable for ever smoking.
Current weekly smoking. Current weekly smokers were individ-
uals who reported smoking at least one cigarette per week at
the time the questionnaire was completed at 16 years (being the
time point most proximal to when DNA methylation data were
obtained). Individuals who reported never having smoked or less
than weekly at any of the three questionnaires were defined as
less than weekly smokers.
Ever weekly smoking. Ever weekly smokers were defined as
individualswho reported at least one cigarette smokedweekly at
any of the three questionnaires. Less than weekly ever smokers
were defined as individuals who had never smoked at least
weekly.
Blood cotinine levels. Nicotine consumption is commonly
measured by cotinine in the blood (50) and in this study blood
cotinine levels were assessed in the ALSPAC offspring between
ages 15 and 17 and is a continuous variable. Cotinine was
assayed from ethylenediaminetetraacetic acid serum plasma
samples taken in a clinical assessment. Plasma samples were
stored at −80◦C and allowed to thaw at room temperature
before use. Cotinine was measured using the Cozart Cotinine
Enzyme Immunoassay (Concateno UK, Abingdon) serum kit
(M155B1). All samples, calibrators and controls were brought to
room temperature before use and were run in duplicate. Where
required, samples were diluted using cotinine-free serum (foetal
calf serum). Absorbance was measured spectrophotometrically
at a wavelength of 450 nm.
Time since initiation and frequency of smoke exposure. We next
investigated patterns of methylation change in relation to dura-
tion and frequency of smoke exposure. Two additional variables
were derived to investigate time since smoking initiation: time
since weekly smoking initiation and time since the individual
first ever smoked. Time since weekly smoking initiation was the
difference between the age of the individuals at methylation
data collection when individuals were aged 17 years and the age
the individual began weekly smoking. For this variable, less than
weekly smokers were assigned a value of ‘0’.
Time since the individual first ever smoked was the differ-
ence between the age of the individuals at methylation data
collection when individuals were 17 years and the age the indi-
vidual first ever tried a cigarette. For this variable, individuals
who had never smoked at the mean age 16 years were assigned
a ‘0’ value.
To investigate methylation differences with frequency of
smoke exposure, we also created a categorical variable based
on information obtained from a questionnaire at age 16. The
categories were: ‘Never smoked a cigarette’, ‘Only ever smoked
cigarettes once’, ‘Used to smoked but doesn’t now’, ‘Sometimes
smokes cigarettes but less than once a week’, ‘Smokes between
1 and 6 cigarettes a week’, ‘Smokes more than 6 cigarettes a
week’ and ‘Smokes 1 or more cigarettes a day’. For this variable,
‘0’ was defined as ‘No’ for ever smoking at age 16.
Finally, we investigated the effect of cumulative cigarettes
ever smoked on DNA methylation, this ordinal variable was
obtained from the questionnaire at 16 years 7 months and
individuals categorized into ‘Never smoked’, ‘Fewer than 5
cigarettes ever smoked’, ‘Between 5 and 19 cigarettes ever
smoked’, ‘Between 20 and 49 cigarettes ever smoked’, ‘Between
50 and 99 cigarettes ever smoked’ and ‘100 or more cigarettes
ever smoked’.
DNA methylation
As part of the ARIES (http://www.ariesepigenomics.org.uk/)
project (25), the Illumina Infinium® HM450 BeadChip assay
(Illumina, Inc., CA, USA) has been used to generate epigenetic
data on 1018 mother–offspring pairs in the ALSPAC cohort. More
details about the sample selection and data processing for the
ARIES study are available in the Supplementary Methods. For
this study we used DNA methylation data from the offspring
to investigate associations between self-reported smoking
behaviours and DNA methylation in adolescence. Specifically,
we investigated methylation β values for 2620 out of 2623 CpGs
previously identified in a large-scale EWAS of smoking (10)which
were available in the normalized dataset for the ARIES offspring
in adolescence (ages 15–17). We also conducted sensitivity
analyses where analyses were adjusted for methylation levels
at the corresponding CpG sites in childhood (before the onset of
smoking) using data from the normalized dataset for the ARIES
offspring at age 7.
Covariates
Frompreviously completed ALSPAC questionnaireswe identified
the following potential confounders: sex, age, parental social
class, smoking by the mother during pregnancy of the offspring
for whom methylation is measured, passive smoke exposure,
DNA methylation at age 7, regular alcohol consumption and
regular cannabis use. The highest parental occupation was used
to allocate the children to family social class groups using the
1991 British Office of Population Censuses and Surveys classifi-
cation. Age was the age recorded at the later DNA methylation
collection time point. Smoking by the mother during pregnancy
of the offspring for whom methylation is measured was defined
as the mother smoking in the first 18 weeks’ gestation. Pas-
sive smoke exposure was derived from maternal report of the
mother or her partner smoking when the offspring was age
12. Regular alcohol consumption was categorized as alcohol
consumed at least once a week or 2 to 4 times a month, depend-
ing on the wording of the question, reported by adolescents
in any of the three questionnaires. Regular cannabis use was
defined as using at least once a week across any of the three
questionnaires.
Smoking could rapidly change cell composition which could
explain the findings of an immediate impact of smoke exposure
onDNAmethylation in peripheral blood. To ensure findingswere
not influenced by variation in cell-type fraction between sam-
ples, the fraction of CD8T-, CD4T-, NK- and B-cells, monocytes
and granulocytes were estimated based on themethylation data
using the estimateCellCounts function in the minfi Bioconductor
package implemented in R (28,29). Models were run adjusted
for cell counts and we also investigated associations between
ever smoking and current weekly smoking with derived cell
counts.
Statistical analysis
Multivariable linear regression. Multivariable linear regression
was used to perform association tests between the smoke expo-
sure variables and β values at each CpG site as the outcome.
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Analyses were run with and without adjustment for several
potential confounders found to be previously associated with
both smoking status and DNA methylation. All regression anal-
yses were performed in Stata (version 15). From the 2620 CpG
sites a Bonferroni-corrected threshold of 1.91 × 10–5 (0.05/2620)
was used to identify ‘EWAS-significant’ hits where association
P-values below this threshold were considered a likely true
positive, worthy of further examination.
Four models for the regression analysis for the own smoking
variables were examined:
• Basic Model: Adjusted for batch and cell count
• Adjusted Model 1: Adjusted for batch, cell count, age, sex,
social class and maternal smoking during pregnancy
• Adjusted Model 2: Adjusted Model 1 covariates, regular
cannabis use, regular alcohol use, passive smoke and
maternal smoking during pregnancy
• Adjusted Model 3: Adjusted Model 2 covariates, additionally
adjusted for methylation at age 7
• Adjusted Model 4: Adjusted Model 2 covariates, additionally
adjusted for cord blood methylation
MI of missing data. Not all individuals in the ARIES cohort had
complete covariate data; maternal smoking behaviour,maternal
social class, regular cannabis use and regular alcohol consump-
tion variables all havemissing data. Tominimize potential selec-
tion bias and improve power in the adjusted models, multivari-
ableMIwas used to imputemissing data for eligible participants.
Missing data MI was performed using the ice command (51) in
Stata (version 15). This method imputes values for covariates
based on patterns for other individuals and other correlated
variables. The ice command uses regression switching (52) and
for thisMI twenty cycles of regression switchingwere carried out
generating 20 imputed datasets. Full details of the MImodels are
outlined in the Supplementary Methods.
Time since initiation and frequency of smoke exposure. In this
analysis, we investigated differences in methylation levels
between each of the smoking categories compared with the
reference group of never smokers using indicator variables.
Models were run adjusted for batch, cell count, age, sex, social
class and maternal smoking during pregnancy. Results were
presented in a heatmap dendrogram generated in R (version
3.2.2) using a hierarchical clustering approach to group sites
with similar patterns of methylation change.
Longitudinal latent class analysis. LLCA was performed using
Mplus v8 (26) to derive smoking classes based on a four-category
ordinal variable with categories ‘none’, ‘less than weekly’,
‘weekly’ and ‘daily’ smoking from the three questionnaire time
points (14, 15 and 16 years). LLCA assumes that variability in
response is due to a latent (unobserved) grouping. Starting with
a single class, a series of models were fitted and theoretical and
statistical steps were taken to decide on the optimal number of
latent classes, for further detail on the derivation of the smoking
latent classes, see Heron et al. (24). The LLCA was applied to
ARIES participants who had information on smoking frequency
available at the three time points. The regression analysis was
performed in Stata, adjusting for batch, cell count, age, sex, social
class and maternal smoking during pregnancy.
Interaction analysis. The 2620 CpG sites associated own
smoking were compared to 568 CpG sites which surpassed a
Bonferroni-correction threshold in a large EWAS of maternal
smoking during pregnancy and cord blood DNAmethylation (27).
There were 119 CpG sites overlapping in both sets of CpG sites
(Table S7). Using these sites, interaction analysis was performed
for each of the four own smoking measures. Multivariable
regression analysis was performed using covariates outlined in
Model 1 (batch, cell count, age, sex, social class and maternal
smoking during pregnancy) along with an interaction term
for maternal smoking during pregnancy and the own smoking
measure.
Supplementary Material
Supplementary Material is available at HMG online.
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